L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea · Delayed Price · Currency is KRW 76,900
-7,500 (-8.89%)
Jun 12, 2026, 3:30 PM KST
L&C BIO Co.,LTD Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -135,144 | -138,175 | 141,596 | 48,361 | 4,544 | 13,814 |
Depreciation & Amortization | 8,416 | 8,234 | 6,754 | 5,654 | 4,508 | 2,902 |
Loss (Gain) From Sale of Assets | 11.3 | -92.81 | 278.45 | -163.01 | -75.75 | -42.98 |
Asset Writedown & Restructuring Costs | 72,520 | 72,520 | - | 2,423 | - | - |
Loss (Gain) From Sale of Investments | 2,669 | 1,081 | -140,830 | -62,178 | 1,740 | 76.02 |
Loss (Gain) on Equity Investments | 278.66 | 195.08 | 2,414 | 437.29 | 806.4 | -3,743 |
Stock-Based Compensation | 539.08 | 270.63 | 149.56 | 138.88 | 375.84 | 727.41 |
Provision & Write-off of Bad Debts | 78.54 | 83.92 | -722.58 | 399.09 | -187.79 | -329.56 |
Other Operating Activities | 71,734 | 70,076 | -15,594 | 19,260 | 3,615 | 4,692 |
Change in Accounts Receivable | -7,167 | -3,149 | -2,766 | -5,429 | -53.77 | -3,285 |
Change in Inventory | 5,809 | 3,475 | -1,437 | -12,151 | -23,269 | -4,554 |
Change in Accounts Payable | 1,172 | -1,906 | 183.95 | -1,158 | 1,709 | 754.1 |
Change in Other Net Operating Assets | -1,517 | -48.4 | 1,406 | -7,728 | 213.3 | -104.08 |
Operating Cash Flow | 19,399 | 12,565 | -8,567 | -12,133 | -6,076 | 10,907 |
Operating Cash Flow Growth | - | - | - | - | - | 47.01% |
Capital Expenditures | -22,451 | -15,810 | -4,715 | -24,503 | -37,531 | -10,251 |
Sale of Property, Plant & Equipment | 2.56 | 2.56 | 544.78 | 256.73 | - | 120.91 |
Cash Acquisitions | 28,654 | -14,332 | -11,678 | - | -1,912 | - |
Sale (Purchase) of Intangibles | -1,400 | -1,225 | -629.02 | -421.08 | 13.05 | -1,137 |
Investment in Securities | 6,838 | -3,130 | 23,295 | 49,856 | -43,867 | -6,240 |
Other Investing Activities | -28,778 | 237.37 | -28,422 | -288.46 | -265.74 | -1,911 |
Investing Cash Flow | -16,298 | -32,890 | -21,946 | 24,634 | -83,633 | -20,488 |
Short-Term Debt Issued | - | 2,770 | 23,600 | 8,381 | 17,949 | - |
Long-Term Debt Issued | - | 70,216 | 19,690 | - | 71,593 | 6,000 |
Total Debt Issued | 75,286 | 72,986 | 43,290 | 8,381 | 89,542 | 6,000 |
Short-Term Debt Repaid | - | -16,360 | - | -9,641 | -8,282 | - |
Long-Term Debt Repaid | - | -32,004 | -8,451 | -1,676 | -1,271 | -663.01 |
Total Debt Repaid | -51,631 | -48,364 | -8,451 | -11,317 | -9,553 | -663.01 |
Net Debt Issued (Repaid) | 23,655 | 24,622 | 34,839 | -2,936 | 79,989 | 5,337 |
Issuance of Common Stock | 18,017 | 17,312 | - | - | - | - |
Repurchase of Common Stock | -10,020 | -10,020 | - | -840 | - | -2,048 |
Dividends Paid | -1,122 | -1,122 | -2,268 | -1,115 | -1,115 | -1,078 |
Other Financing Activities | 1,287 | 1,332 | 1,260 | 735.98 | 53.6 | 2,487 |
Financing Cash Flow | 31,817 | 32,123 | 33,830 | -4,155 | 78,928 | 4,697 |
Foreign Exchange Rate Adjustments | 538.3 | 163.73 | 19.6 | 11.32 | -9.19 | - |
Miscellaneous Cash Flow Adjustments | 639.18 | 639.18 | - | - | - | 0 |
Net Cash Flow | 36,096 | 12,601 | 3,337 | 8,357 | -10,790 | -4,884 |
Free Cash Flow | -3,052 | -3,245 | -13,282 | -36,636 | -43,607 | 655.69 |
Free Cash Flow Growth | - | - | - | - | - | -85.11% |
Free Cash Flow Margin | -3.11% | -3.80% | -18.44% | -55.57% | -82.95% | 1.44% |
Free Cash Flow Per Share | -127.00 | -136.49 | -585.50 | -1481.90 | -1922.29 | 29.41 |
Cash Interest Paid | 1,652 | 1,859 | 497.63 | 530.96 | 158.69 | 23.01 |
Cash Income Tax Paid | 173.15 | -282.58 | 14,870 | 1,221 | 1,247 | -514.3 |
Levered Free Cash Flow | 103,515 | 92,373 | 627.58 | -24,219 | -49,766 | -8,801 |
Unlevered Free Cash Flow | 107,182 | 96,039 | 2,641 | -20,361 | -47,843 | -8,513 |
Change in Working Capital | -1,703 | -1,628 | -2,613 | -26,466 | -21,401 | -7,190 |